List view / Grid view

Breast cancer

 

news

Manipulating cells’ shapes could treat breast cancer

4 March 2015 | By The Institute of Cancer Research

Changing the shape of breast cancer cells could make the disease more sensitive to treatments – even driving the body’s own inflammatory response against a tumour – a new study shows...

news

Merck Serono to collaborate with The Institute of Cancer Research, London, and Wellcome Trust to co-develop anti-cancer drugs

8 October 2014 | By The Wellcome Trust, The Institute of Cancer Research & Merck Serono

Merck Serono, The Institute of Cancer Research, and the Wellcome Trust, London, have announced a co-development and license agreement building on two independent research programs at both the ICR and Merck Serono to identify inhibitors of tankyrase, an enzyme of the poly (ADP-ribose) polymerase family...

article

Antibody Discovery Technologies: the partnership between academia and biopharma in the therapeutic monoclonal antibody success story

3 October 2014 | By , ,

The use of monoclonal antibodies and antibody-based molecules as therapeutics to treat patients suffering with severe disease has become a major success story. Due to the exquisite specificity with which they interact with their antigen and the fact that their large binding surface can intervene at sites and targets not…